Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy
Among men, prostate cancer has a high prevalence, with relatively lower cancer-specific mortality risk compared to lung and colon cancer. Prostate-specific antigen (PSA) screening has increased prostate cancer awareness since its implementation as a screening tool almost 25 years ago, but, due to th...
Saved in:
Main Authors: | Al B. Barqawi, Kevin J. Krughoff, Khadijah Eid |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Advances in Urology |
Online Access: | http://dx.doi.org/10.1155/2012/862639 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Targeted Focal Therapy in the Management of Low-Risk Prostate Cancer: Update on Current Challenges
by: Daniel W. Smith, et al.
Published: (2012-01-01) -
Focal Treatment of Prostate Cancer with Vascular-Targeted Photodynamic Therapy
by: Scott E. Eggener, et al.
Published: (2008-01-01) -
Focal Therapy for Prostate Cancer: Recent Advances and Insights
by: Francesco Lasorsa, et al.
Published: (2024-12-01) -
Focal Laser Ablation of Prostate Cancer: Definition, Needs, and Future
by: Pierre Colin, et al.
Published: (2012-01-01) -
Focal therapy of prostate cancer: Use of artificial intelligence to define tumour volume and predict treatment outcomes
by: Wayne G. Brisbane, et al.
Published: (2025-01-01)